News and Press

Press releases

2024

2024-04-02 14:00 Bulletin from the Extraordinary General Meeting on Tuesday 2[nd] of April in Diagonal Bio AB Regulatory

Today, 2[nd] April 2024, an Extraordinary General Meeting was held in Diagonal Bio AB, reg. no. 559248–8984. Below is a summary of the resolutions passed...

2024-02-28 17:50 Diagonal Bio appoints Karin Wehlin as new CEO Regulatory MAR

Diagonal Bio AB (publ.) (“Diagonal Bio” or “the Company”) is pleased to announce that the Board of Directors has appointed Karin Wehlin as Chief...

2024-02-28 17:45 Notice to attend the extraordinary general meeting of Diagonal Bio AB Regulatory

Shareholders in Diagonal Bio AB, 559248-8984, are hereby invited to attend an extraordinary general meeting on Tuesday, 2nd of April, 2024, at 13:00 CET...

2024-02-28 17:40 The Board of Directors decides on a preferential rights issue of units in order to finance future development Regulatory MAR

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR TO THE UNITED STATES, AUSTRALIA, HONG KONG, JAPAN, CANADA, NEW ZEALAND, SWITZERLAND...

2024-02-28 17:31 Diagonal Bio AB Year-end Report 2023 Regulatory

“Looking back at 2023, I am proud to point out the significant steps we have made in our development, including the key achievements such as the CE-marking...